DE602005013542D1 - Behandlung der oralen und darm mukositis durch verabreichung von menschlichem il-18 - Google Patents
Behandlung der oralen und darm mukositis durch verabreichung von menschlichem il-18Info
- Publication number
- DE602005013542D1 DE602005013542D1 DE602005013542T DE602005013542T DE602005013542D1 DE 602005013542 D1 DE602005013542 D1 DE 602005013542D1 DE 602005013542 T DE602005013542 T DE 602005013542T DE 602005013542 T DE602005013542 T DE 602005013542T DE 602005013542 D1 DE602005013542 D1 DE 602005013542D1
- Authority
- DE
- Germany
- Prior art keywords
- mucositis
- human
- treatment
- oral
- darm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010028116 Mucosal inflammation Diseases 0.000 title 1
- 201000010927 Mucositis Diseases 0.000 title 1
- 101000960954 Homo sapiens Interleukin-18 Proteins 0.000 abstract 2
- 206010056340 Diabetic ulcer Diseases 0.000 abstract 1
- 206010064147 Gastrointestinal inflammation Diseases 0.000 abstract 1
- 102100039898 Interleukin-18 Human genes 0.000 abstract 1
- 208000005230 Leg Ulcer Diseases 0.000 abstract 1
- 208000004852 Lung Injury Diseases 0.000 abstract 1
- 206010072170 Skin wound Diseases 0.000 abstract 1
- 208000002847 Surgical Wound Diseases 0.000 abstract 1
- 206010069363 Traumatic lung injury Diseases 0.000 abstract 1
- 208000018925 gastrointestinal mucositis Diseases 0.000 abstract 1
- 102000043959 human IL18 Human genes 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 231100000515 lung injury Toxicity 0.000 abstract 1
- 208000003265 stomatitis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60301204P | 2004-08-20 | 2004-08-20 | |
| PCT/US2005/029358 WO2006023623A2 (en) | 2004-08-20 | 2005-08-18 | Methods of healing wounds by administering human il-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602005013542D1 true DE602005013542D1 (de) | 2009-05-07 |
Family
ID=35968167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602005013542T Active DE602005013542D1 (de) | 2004-08-20 | 2005-08-18 | Behandlung der oralen und darm mukositis durch verabreichung von menschlichem il-18 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7595039B2 (de) |
| EP (2) | EP2161032B1 (de) |
| JP (1) | JP4912306B2 (de) |
| KR (1) | KR20070050924A (de) |
| CN (1) | CN101039696B (de) |
| AT (2) | ATE426410T1 (de) |
| AU (1) | AU2005277404A1 (de) |
| BR (1) | BRPI0514445A (de) |
| CA (1) | CA2577777A1 (de) |
| CY (1) | CY1108991T1 (de) |
| DE (1) | DE602005013542D1 (de) |
| DK (1) | DK1793859T3 (de) |
| ES (2) | ES2372728T3 (de) |
| HK (1) | HK1109054A1 (de) |
| IL (1) | IL181286A0 (de) |
| MX (1) | MX2007002134A (de) |
| NO (1) | NO20071238L (de) |
| NZ (1) | NZ552837A (de) |
| PL (1) | PL1793859T3 (de) |
| PT (1) | PT1793859E (de) |
| RU (1) | RU2387455C2 (de) |
| SI (1) | SI1793859T1 (de) |
| WO (1) | WO2006023623A2 (de) |
| ZA (1) | ZA200700524B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ520392A (en) * | 2000-02-10 | 2005-04-29 | Abbott Lab | Antibodies that bind human interleukin-18 and methods of making and using |
| US7968684B2 (en) | 2003-11-12 | 2011-06-28 | Abbott Laboratories | IL-18 binding proteins |
| JP6005736B2 (ja) | 2011-06-13 | 2016-10-12 | ニューメディシンズ，インコーポレーテッド | Ｉｌ−１２を用いる皮膚損傷の軽減 |
| EP3041864B1 (de) * | 2013-09-05 | 2021-07-21 | AB2 Bio SA | Il-18-bindendes protein (il-18bp) bei entzündungskrankheiten |
| AU2016227644B2 (en) | 2015-03-05 | 2022-06-16 | Ab2 Bio Sa | IL-18 Binding Protein (IL-18BP) and antibodies in inflammatory diseases |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0692536B1 (de) | 1994-07-14 | 2000-11-22 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Protein, das Interferon-Gamma Herstellung induziert und monoklonaler Antikörper dagegen |
| JP4004088B2 (ja) | 1995-09-26 | 2007-11-07 | 株式会社林原生物化学研究所 | 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質 |
| TW581771B (en) | 1994-11-15 | 2004-04-01 | Hayashibara Biochem Lab | Recombinant production of a polypeptide for inducing interferon-gamma production, and monoclonal antibody against the polypeptide |
| US5680795A (en) | 1995-07-05 | 1997-10-28 | Norco Inc. | Mechanical drive assembly incorporating counter-spring biassed radially-adjustable rollers |
| JP4024366B2 (ja) * | 1996-11-29 | 2007-12-19 | 株式会社林原生物化学研究所 | ポリペプチド |
| TWI227136B (en) * | 1998-05-21 | 2005-02-01 | Smithkline Beecham Corp | Novel pharmaceutical composition for the prevention and/or treatment of cancer |
| NZ523123A (en) * | 2000-06-02 | 2005-12-23 | Smithkline Beecham Corp | Methods of treating viral diseases with IL-18 and IL-18 combinations with anti-viral drugs |
| CZ20024085A3 (cs) * | 2000-06-15 | 2003-05-14 | Smithkline Beecham Corporation | Způsob přípravy fyziologicky aktivního IL-18 polypeptidu |
| US7098373B2 (en) * | 2001-07-12 | 2006-08-29 | Hitoshi Mizutani | IL-18 transgenic animal |
| WO2004024180A1 (en) * | 2002-09-16 | 2004-03-25 | Agennix Incorporated | Lactoferrin compositions and methods of wound treatment |
| AU2003295331A1 (en) * | 2002-09-19 | 2004-04-23 | Centocor, Inc. | Method of inducing maturation of dendritic cells and uses therefor |
| US20050075277A1 (en) * | 2003-07-10 | 2005-04-07 | Agennix Incorporated | Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects |
-
2005
- 2005-08-18 SI SI200530665T patent/SI1793859T1/sl unknown
- 2005-08-18 CN CN2005800338197A patent/CN101039696B/zh not_active Expired - Fee Related
- 2005-08-18 DK DK05789011T patent/DK1793859T3/da active
- 2005-08-18 BR BRPI0514445-0A patent/BRPI0514445A/pt not_active IP Right Cessation
- 2005-08-18 ES ES09155870T patent/ES2372728T3/es active Active
- 2005-08-18 NZ NZ552837A patent/NZ552837A/en not_active IP Right Cessation
- 2005-08-18 MX MX2007002134A patent/MX2007002134A/es active IP Right Grant
- 2005-08-18 EP EP09155870A patent/EP2161032B1/de active Active
- 2005-08-18 AT AT05789011T patent/ATE426410T1/de active
- 2005-08-18 PT PT05789011T patent/PT1793859E/pt unknown
- 2005-08-18 WO PCT/US2005/029358 patent/WO2006023623A2/en active Application Filing
- 2005-08-18 CA CA002577777A patent/CA2577777A1/en not_active Abandoned
- 2005-08-18 AU AU2005277404A patent/AU2005277404A1/en not_active Abandoned
- 2005-08-18 PL PL05789011T patent/PL1793859T3/pl unknown
- 2005-08-18 EP EP05789011A patent/EP1793859B1/de active Active
- 2005-08-18 ES ES05789011T patent/ES2322605T3/es active Active
- 2005-08-18 DE DE602005013542T patent/DE602005013542D1/de active Active
- 2005-08-18 KR KR1020077003853A patent/KR20070050924A/ko not_active Application Discontinuation
- 2005-08-18 RU RU2007110166/14A patent/RU2387455C2/ru not_active IP Right Cessation
- 2005-08-18 JP JP2007528002A patent/JP4912306B2/ja active Active
- 2005-08-18 AT AT09155870T patent/ATE526057T1/de not_active IP Right Cessation
- 2005-08-19 US US11/207,847 patent/US7595039B2/en active Active
-
2007
- 2007-01-18 ZA ZA200700524A patent/ZA200700524B/en unknown
- 2007-02-12 IL IL181286A patent/IL181286A0/en unknown
- 2007-03-07 NO NO20071238A patent/NO20071238L/no not_active Application Discontinuation
- 2007-12-03 HK HK07113219.1A patent/HK1109054A1/xx not_active IP Right Cessation
-
2009
- 2009-05-07 CY CY20091100489T patent/CY1108991T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60331236D1 (de) | Orale zusammensetzungen zur behandlung von diabetes | |
| DE502005010615D1 (de) | Mittel zur behandlung von entzündlichen erkrankungen | |
| ATE432693T1 (de) | Kombinationstherapie zur behandlung von diabetes und dadurch bedingten leiden sowie zur behandlung von mittels erhöhung des glp-1-spiegels im blut verbesserten leiden | |
| DE60027415D1 (de) | Zusammensetzung für die Verhinderung der Glattmuskelkrankheiten, die Ascorbat, Arginin und Magnesium enthält | |
| ATE525070T1 (de) | Silbininkomponente zur behandlung von hepatitis | |
| DE602005013542D1 (de) | Behandlung der oralen und darm mukositis durch verabreichung von menschlichem il-18 | |
| DE60115432D1 (de) | Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen | |
| DE602004010691D1 (de) | Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie | |
| DK1596879T3 (da) | Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis | |
| DE602004009166D1 (de) | Neue Analoga von Nitrobenzylthioinosin | |
| DE602007008567D1 (de) | Pharmazeutische Zusammensetzungen zur oralen Verabreichung bei der Behandlung von Adipositas-Patienten | |
| DE502004011874D1 (de) | Flupirtine-präparat zur behandlung von neurodegeneetes mellitus | |
| ATE447944T1 (de) | Verwendung von formoterol in der prophylaktischen und/oder therapeutischen behandlung von muskelschwund und/oder kachexie-syndrom im zusammenhang mit katabolischen zuständen bei bestimmten krankheiten, wie z.b. krebs, aids, infektionen, diabetes und andere | |
| DE602004021915D1 (de) | Verwendung der cinchonapflanze zur herstellung eines medikamentes zur stimulierung der angiogenese | |
| DE50310383D1 (de) | Humanes chondroosteomodulin (tig2), herstellung und verwendung zur behandlung oder diagnose von knochen- und knorpelerkrankungen, fettsucht sowie entzündlichen erkrankungen und hauterkrankungen | |
| DE60308862D1 (de) | Verbindungen und zusammensetzungen zur behandlung von diabetes und erkrankungen, die mit diabetes in zusammenhang stehen | |
| ATE425765T1 (de) | Verwendung von kollagen in kombination mit sauerstoff- und ozon-freisetzenden perfluorkohlenwasserstoffen zur herstellung eines medikaments zur behandlung von hautverletzungen | |
| ATE444071T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von hauterkrankungen | |
| ATE458477T1 (de) | Pharmazeutische zusammensetzung enthaltend in assoziation ubidecarenon, dexpanthenol und chlorhexidine oder eines seiner pharmazeutischen unbedenklichen salze zur anwendung auf der haut | |
| RU2004104555A (ru) | Способ лечения диабетической ретинопатии, осложненной гемофтальмом | |
| NO20064828L (no) | Ny anvendelse av peptidforbindelser for behandling av smerte i smertefull diabetisk neuropati. | |
| TR200301800A2 (tr) | Bir farmasötik terkip. | |
| FI20021180A0 (fi) | Lääketieteellisen tutkimus- ja käsittelypöydän jatkesovitelma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |